Expert Commentary

Webcast: Hormonal contraception and risk of venous thromboembolism

OBG Manag. 2016 July;28(7)
By
Ronald T. Burkman, MD
Author and Disclosure Information

Which hormonal contraceptives increase the risk of venous thromboembolism (VTE)? Are there differences by specific preparations? What groups of women are at particularly high risk for VTE with hormonal contraception use? What the data tell us.

 

Vidyard Video

Access Dr. Burkman's Webcasts on contraception:

Helpful resource for your practice:

Recommended Reading

Webcast: Oral contraceptives and breast cancer: What’s the risk?
MDedge ObGyn
Immediate postpartum IUD insertion causes little pain, distress
MDedge ObGyn
Oral contraceptive efficacy unaffected by dimethyl fumarate
MDedge ObGyn
VIDEO: Expert roundtable explores 50 years of contraception
MDedge ObGyn
Study confirms role of oral contraceptives in preventing ovarian cancer
MDedge ObGyn
AAP, NASPAG issue joint guidance on menstruation management in teens with disabilities
MDedge ObGyn
Condom basics
MDedge ObGyn
Supreme Court will not hear pharmacy religious liberty case
MDedge ObGyn
Dapivirine vaginal ring sharply reduces HIV infection risk
MDedge ObGyn
The role ob.gyns. can play in preventing Zika virus
MDedge ObGyn